Skip to main content

ADVERTISEMENT

Videos

Sharma Figure 1
Clinical Videos
06/10/2024

Arun Sharma, DM; Harsimran Bhatia, MD; Vansha Mehta, MBBS; Manphool Singhal, MD, DNB; Parag Barwad, DM; Sanjeev Hanumantacharya Naganur, DM

Arun Sharma, DM; Harsimran Bhatia, MD...
Video Supplement to "Rare Case of Peripherally Calcified Ductus Arteriosus Aneurysm in an Adult" (Clinical Image).
Video Supplement to "Rare Case of Peripherally Calcified Ductus Arteriosus Aneurysm in an Adult" (Clinical Image).
Video Supplement to "Rare Case...
06/10/2024
Journal of Invasive Cardiology
Key Challenges in Accurately Diagnosing Bipolar Disorder
Videos
06/10/2024

Featuring Rakesh Jain, MD

Featuring Rakesh Jain, MD
Dr Jain discusses diagnosing and differentiating bipolar disorder from other mental health conditions, the importance of a thorough patient history, and more!
Dr Jain discusses diagnosing and differentiating bipolar disorder from other mental health conditions, the importance of a thorough patient history, and more!
Dr Jain discusses diagnosing and...
06/10/2024
Psych Congress Network
David Rubin
Video
06/10/2024
Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.
Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.
Dr Rubin discusses the results...
06/10/2024
Advances in Inflammatory Bowel Disease Network
Joshua Brody, MD
Videos
06/08/2024

Featuring Joshua Brody, MD

Featuring Joshua Brody, MD
According to data presented at the 2024 ASCO Annual Meeting, epcoritamab plus rituximab and lenalidomide continued to demonstrate deep, durable responses for previously untreated FL, and epcoritamab as maintenance therapy showed efficacy and...
According to data presented at the 2024 ASCO Annual Meeting, epcoritamab plus rituximab and lenalidomide continued to demonstrate deep, durable responses for previously untreated FL, and epcoritamab as maintenance therapy showed efficacy and...
According to data presented at...
06/08/2024
Oncology
Luciano Costa, MD
Videos
06/07/2024

Featuring Luciano Costa, MD

Featuring Luciano Costa, MD
Cilta-cel improved outcomes for patients with lenalidomide-refractory functional high-risk multiple myeloma vs standard of care, according to data presented by Luciano Costa, MD, at the 2024 ASCO Annual Meeting.
Cilta-cel improved outcomes for patients with lenalidomide-refractory functional high-risk multiple myeloma vs standard of care, according to data presented by Luciano Costa, MD, at the 2024 ASCO Annual Meeting.
Cilta-cel improved outcomes for...
06/07/2024
Oncology
Maria-Victoria Mateos, MD, PhD
Conference Coverage
06/07/2024

Featuring Maria-Victoria Mateos, MD, PhD

Featuring Maria-Victoria Mateos, MD, ...
Maria-Victoria Mateos, MD, PhD, presents results from the phase 3 DREAMM-7 trial, which demonstrated the efficacy of belantamab mafodotin plus bortezomib and dexamethasone as a potential new standard of care for patients with R/R MM.
Maria-Victoria Mateos, MD, PhD, presents results from the phase 3 DREAMM-7 trial, which demonstrated the efficacy of belantamab mafodotin plus bortezomib and dexamethasone as a potential new standard of care for patients with R/R MM.
Maria-Victoria Mateos, MD, PhD,...
06/07/2024
Oncology
Rebecca Shatsky, MD, University of California, San Diego
Videos
06/07/2024
Rebecca Shatsky, MD
Rebecca Shatsky, MD, shares results on datopotamab deruxtecan plus durvalumab for certain patients with advanced breast cancer from the I-SPY2.2 trial.
Rebecca Shatsky, MD, shares results on datopotamab deruxtecan plus durvalumab for certain patients with advanced breast cancer from the I-SPY2.2 trial.
Rebecca Shatsky, MD, shares...
06/07/2024
Oncology
Ed Loftus
Video
06/06/2024
Dr Loftus recaps his poster presentation on a subanalysis from the upadacitinib phase 3 trials in Crohn's disease examining the effect on anxiety, depression, fatigue, and bowel urgency.
Dr Loftus recaps his poster presentation on a subanalysis from the upadacitinib phase 3 trials in Crohn's disease examining the effect on anxiety, depression, fatigue, and bowel urgency.
Dr Loftus recaps his poster...
06/06/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Conference Coverage
06/06/2024
Dr Long discusses the management of acute severe ulcerative colitis, including initiating therapy, when and how to assess response, options for rescue treatment, and the role of the surgeon in determining the best course of care.
Dr Long discusses the management of acute severe ulcerative colitis, including initiating therapy, when and how to assess response, options for rescue treatment, and the role of the surgeon in determining the best course of care.
Dr Long discusses the management...
06/06/2024
Advances in Inflammatory Bowel Disease Network